Ubisol Q-10 in Combination with Methylene Blue as a Treatment for Alzheimer’s Disease in a Transgenic Mouse Model by Pupulin, Simon Anthony, A
University of Windsor
Scholarship at UWindsor
UWill Discover Undergraduate Conference UWill Discover 2016
Mar 29th, 1:00 PM - 2:20 PM
Ubisol Q-10 in Combination with Methylene Blue
as a Treatment for Alzheimer’s Disease in a
Transgenic Mouse Model
Simon Anthony Pupulin A
University of Windsor, pupulins@uwindsor.ca
Follow this and additional works at: http://scholar.uwindsor.ca/uwilldiscover
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
This Event is brought to you for free and open access by the UWill Discover! at Scholarship at UWindsor. It has been accepted for inclusion in UWill
Discover Undergraduate Conference by an authorized administrator of Scholarship at UWindsor. For more information, please contact
scholarship@uwindsor.ca.
Simon Anthony Pupulin A, "Ubisol Q-10 in Combination with Methylene Blue as a Treatment for Alzheimer’s Disease in a Transgenic
Mouse Model" (March 29, 2016). UWill Discover Undergraduate Conference. Paper 2.
http://scholar.uwindsor.ca/uwilldiscover/2016/posters2016/2
Ubisol	Q-10	in	Combina0on	with	Methylene	Blue	as	a	Treatment	for	Alzheimer’s	Disease	
Simon	Pupulin,	Krithika	Muthukumaran,	Siyaram	Pandey		
Introduc0on	
	
Control	(Untreated)	 Ubisol-Q10		Treatment	 Wildtype	
Am
yl
oi
d	
50
x	
M
ag
	
Co
ng
o	
Re
d	
50
x	
M
ag
	
Past	Results	(Ubisol-Q10)		
	
Past	Results	(Methylene	Blue)		
	
References	
	
1.  World	Health	OrganizaKon-	DemenKa	Fact	Sheet.	(2015,	March	1).	Retrieved	13	March,	2016,	from	hTp://
www.who.int/mediacentre/factsheets/fs362/en/	
2.  Society	for	Neuroscience.	(2011,	September	29).	Retrieved	13	March,	2016,	from	www.sfn.org/index.aspx?
pagename=publicaKons_rd_alzheimers 		
3.  Eckert,	A.,	SchmiT,	K.,	&	Götz,	J.	(2011).	Mitochondrial	dysfuncKon	-	the	beginning	of	the	end	in	Alzheimer's	disease?	
Separate	and	synergisKc	modes	of	tau	and	amyloid-β	toxicity.	Alzheimers	Res	Ther	Alzheimer's	Research	&	Therapy,	
3(2),	15.	
4.  Zakaria,	A.,	Hamdi,	N.,	&	Abdel-Kader,	R.	M.	(2015).	Methylene	Blue	Improves	Brain	Mitochondrial	ABAD	FuncKons	
and	Decreases	Aβ	in	a	Neuroinﬂammatory	Alzheimer’s	Disease	Mouse	Model.	Molecular	Neurobiology	Mol	Neurobiol,	
53(2),	1220-1228.		
C o n tr o l T r e a te d W ild  typ e
0
1 0 0 0
2 0 0 0
3 0 0 0
S e ru m  le v e ls  o f h u m a n  a m y lo id -ß  (1 -4 0 )
H
u
m
a
n
 a
m
y
lo
id
-ß
 (
1
-4
0
) 
in
 p
g
/m
l
Figure	3.	Ubisol-Q10	Reduces	Toxic	Amyloid-
Beta	In	Circula0on	(ELISA).	Levels	of	human	
amyloid-β	protein	averaged	over	3	trials	in	
blood	samples	from	three	transgenic	mice	in	
each	group.		
Figure	4.	Eﬀect	of	Methylene	Blue	(MB)	Treatment	on	
Mitochondrial	ROS	Levels.[4]	The	lipopolysaccharide	(LPS)	
mouse	model	displayed	signiﬁcant	increase	in	ﬂuorescence	
indicaKng	an	increase	in	mitochondrial	free	radicals	
compared	to	the	control	group.	LPS	+	MB	showed	a	
signiﬁcant	diﬀerence	in	ROS	compared	to	both	LPS	and	
control	groups.	
Alzheimer’s	disease	(AD)	is	a	progressive	neurodegeneraKve	disorder	ooen	associated	with	memory	impairment.			
According	to	the	World	Health	OrganizaKon,	approximately	48	million	people	worldwide	live	with	the	disease	and	this	
number	is	expected	to	triple	by	2050.[1]			
As	AD	is	a	poorly	understood	disease,	there	is	currently	no	cure	for	the	
degeneraKon	it	causes.		However,	some	studies	have	shown	a	link	between	
Alzheimer’s	disease	and	oxidaKve	stress.		Elevated	reacKve	oxygen	species	(ROS)	
are	a	result	of	ineﬃciency	in	the	electron	transport	chain	in	the	mitochondria	
and	can	induce	premature	cellular	senescence.		The	death	of	these	neurons	can	
lead	to	the	formaKon	of	neuroﬁbrillary	tangles	and	amyloid	plaques,	
characterisKc	of	the	disease,	in	regions	of	the	hippocampus	and	cerebral	cortex.	
It	has	been	demonstrated	that	the	water	soluble	formulaKon	of	the	
anK-oxidant	CoQ10	(Ubisol-Q10)	can	stabilize	the	mitochondria	and	
prevent	neuronal	loss	by	ulKmately	reducing	the	generaKon	of	free	
radicals.		The	neuroprotecKve	properKes	of	Ubisol	Q10	have	been	
tested	in	transgenic	mouse	models	expressing	the	human	amyloid	
precursor	protein	and	mutant	human	presinilin-1.	Methylene	blue	
has	also	been	found	to	improve	cogniKve	funcKon	in	AD	paKents	and	
reduce	amyloid	plaque	levels,	providing	successful	neuroprotecKon.[4]		
Objec0ve:	UlKmately,	the	goal	of	this	study	is	to	use	a	combinaKon	of	both	Ubisol-Q10	and	methylene	blue	to	study	how	
eﬃcient	this	collaKon	of	treatments	is	in	postponing	premature	cellular	senescence	in	transgenic	mouse	models.	
Figure	2.	Impairment	of	the	ETC	in	AD.[3]		
Figure	1.	AD	primarily	aﬀects	hippocampus																
and	cerebral	cortex	regions	of	the	brain.[2]	
Figure	5.	Ubisol-Q10	
Neuroprotec0on	Results.	DetecKon	
of	extracellular	amyloid	plaques	
using	Congo	Red	Fluorescent	dye	
and	anK-human	amyloid-β	
anKbodies.					
Methodology	
	
Behavioural	
Studies	
• In	partnership	with	Dr.	Jerome	Cohen’s	psychology	research	lab,	mice	in	various	groups	will	be	
subject	to	various	tests	of	memory	and	cogniKon		
Amyloid-β	
Levels	
• Aoer	1.5	years,	mice	will	be	sacriﬁced	and	blood	cells	will	be	analyzed	for	amyloid-β	proteins	
through	ELISA	
• Various	staining	techniques	will	be	implemented	to	quanKtaKvely	assess	the	presence	of	
amyloid-β	plaques	through	Congo	Red	and	anK-human	amyloid-β	anKbody	staining	
Glial	Cell	
AcKvaKon	
• Astrocytes:	detecKon	of	astrocytes	will	be	primarily	through	glial	ﬁbrillary	acidic	proteins	
(GFAP)	idenKﬁcaKon	
• Microglia:	Iba1	(ionized	calcium-binding	adapter	molecule	1)	will	be	monitored	for	microglia	
acKvaKon	
Group	 Descrip0on	
1.	Control	Group	 No	treatment	
2.	Ubisol-Q10	 Oral-supplemented	(6mg/kg/day)	
3.	Methylene	Blue	 Injected	(4	mg/kg/day)	
4.	Ubisol-Q10	and	Methylene	Blue	 Both	injecKon	(MB)	and	oral-supplement	(CoQ10)	
